FDA Inspection 1131818 — Biofarma US
The FDA completed an inspection of Biofarma US on Sep 28, 2020 in East Windsor, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 28, 2020
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- East Windsor, NJ (United States)